Quotient Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$477K Sell
5,201
-97
-2% -$8.49K 0.01% 219
2026
Q1
$452K Buy
5,298
+2,138
+68% +$191K 0.01% 213
2025
Q4
$250K Sell
3,160
-1,857
-37% -$146K 0.01% 303
2025
Q3
$401K Sell
5,017
-483
-9% -$41.2K 0.01% 230
2025
Q2
$500K Sell
5,500
-1
-0% -$91 0.01% 189
2025
Q1
$515K Buy
5,501
+2,443
+80% +$219K 0.02% 174
2024
Q4
$278K Sell
3,058
-81
-3% -$7.73K 0.01% 260
2024
Q3
$326K Sell
3,139
-593
-16% -$60.4K 0.01% 236
2024
Q2
$362K Sell
3,732
-6,190
-62% -$571K 0.01% 215
2024
Q1
$893K Sell
9,922
-23,565
-70% -$2M 0.03% 113
2023
Q4
$2.67M Buy
+33,487
New +$2.52M 0.1% 78

Other funds holding CL

Quotient Wealth Partners's CL Position: Q2 2026 in Review

Quotient Wealth Partners reduced its Colgate-Palmolive (CL) stake by 1.8% in Q2 2026, selling an estimated $8.49K and leaving 5,201 shares worth $477K. The position accounts for 0.01% of the portfolio, ranked #219.

Quotient Wealth Partners first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.67M in Q4 2023. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Quotient Wealth Partners held 5,201 shares of Colgate-Palmolive worth $477K as of Q2 2026.
  • Quotient Wealth Partners sold 97 Colgate-Palmolive shares in Q2 2026, an estimated $8.49K.
  • Colgate-Palmolive made up 0.01% of Quotient Wealth Partners's portfolio in Q2 2026, its #219 holding.
  • Quotient Wealth Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Quotient Wealth Partners's Colgate-Palmolive position peaked at $2.67M in Q4 2023.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.